Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3-iodo-2-propynylbutylcarbamate
2. 3-ipbc
3. 3-iodo-2-propynyl-butylcarbamate
4. Iodopropynyl Butylcarbamate
1. 55406-53-6
2. Iodopropynyl Butylcarbamate
3. Ipbc
4. Woodlife
5. Troysan Kk-108a
6. Caswell No. 501a
7. Butyl-3-iodo-2-propynylcarbamate
8. 3-iodo-2-propynyl Butyl Carbamate
9. 3-iodoprop-2-yn-1-yl N-butylcarbamate
10. 603p14dheb
11. 3-iodo-2-propyn-1-yl N-butylcarbamate
12. Carbamic Acid, Butyl-3-iodo-2-propynyl Ester
13. 3-iodoprop-2-ynyl Butylcarbamate
14. 3-ipbc
15. 3-iodo-2-propynyl-butylcarbamate
16. Refchem:502679
17. Iodopropynyl Butyl Carbamate
18. 259-627-5
19. 3-iodo-2-propynylbutylcarbamate
20. 3-iodoprop-2-yn-1-yl Butylcarbamate
21. Iodocarb
22. 3-iodo-2-propynyl N-butylcarbamate
23. 3-iodoprop-2-ynyl N-butylcarbamate
24. Carbamic Acid, Butyl-, 3-iodo-2-propynyl Ester
25. 1-iodoprop-1-yn-3-yl N-n-butylcarbamate
26. 3-iodo-2-propynyl-n-butylcarbamate
27. Mfcd00072438
28. C8h12ino2
29. Dtxsid0028038
30. Chebi:83279
31. 85045-09-6
32. Dtxcid908038
33. Cas-55406-53-6
34. 3-iodo-2-propynyl N-butylcarbamate-d9
35. Hsdb 7314
36. Einecs 259-627-5
37. Epa Pesticide Chemical Code 107801
38. Brn 2248232
39. Iodocarbe
40. Unii-603p14dheb
41. 3-iodo-2-propynyl-n-butyl Carbamate
42. 1246815-08-6
43. Iodocarb 100 Microg/ml In Acetonitrile
44. 3-iodo-2-propynylbutyl Carbamate
45. Ipbc [mi]
46. Schembl114369
47. Chembl1893913
48. 3-iodo-2-propynyl Butylcarbamate #
49. 3-iodoprop-2-yn-1-ylbutylcarbamate
50. Tox21_201864
51. Tox21_301117
52. Akos015905567
53. Cs-w010051
54. Fi16109
55. Gs-3240
56. Ncgc00164376-01
57. Ncgc00164376-02
58. Ncgc00164376-03
59. Ncgc00164376-04
60. Ncgc00164376-05
61. Ncgc00255017-01
62. Ncgc00259413-01
63. Sy052464
64. 3-iodo-2-propynyl N-butylcarbamate, 97%
65. Iodopropynyl Butylcarbamate [vandf]
66. 3-iodo-2-propynyl Butyl Carbbamate
67. Db-262370
68. I0666
69. Iodopropynyl Butyl Carbamate [mart.]
70. Ns00000275
71. N-butylcarbamic Acid 3-iodo-2-propynyl Ester
72. 06i536
73. 3-iodo-2-propynylbutylcarbamate [hsdb]
74. F050829
75. Q2928998
76. Carbamic Acid, N-butyl-, 3-iodo-2-propyn-1-yl Ester
77. 3-iodo-2-propynyl N-butylcarbamate, Analytical Standard
| Molecular Weight | 281.09 g/mol |
|---|---|
| Molecular Formula | C8H12INO2 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 38.3 |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 192 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
...IPBC was administered orally in 0.5% carboxymethylcellulose to groups of male and female Crl:CD/BR rats in the following manner: Groups of 5 male and 5 female rats (groups A and B) received either a single oral high dose of radiolabelled IPBC (125 mg/kg) or a repeated low oral dose of non-radiolabelled IPBC followed by a single radiolabelled dose (20 mg/kg). Separate groups of rats (9/sex/group, groups C and D) received single oral doses (20 and 125 mg/kg) of radiolabelled IPBC, and 3 rats/sex were sacrificed at 2, 4, and 120 hours post-dose for determination of tissue distribution of radioactivity. Urine, feces and expired air were collected at 24 hr intervals for groups A and B, while urine and feces were collected from groups C and D. Absorption of test chemical at the low and high dose was between 80-90% for all dose groups, as suggested by excretion data showing the majority of a dose eliminated through urine or exhaled air. Excretion of IPBC-derived radioactivity was mainly via the urine, with between 50-70% of an administered dose excreted by this route at 168 hours post-dose. Feces was a minor route of excretion in all dose groups (4-7% of the administered dose), while radiolabelled CO2 constituted between 18-24% of the administered dose. Repeated low oral dosing or a single high oral dose appeared to result in a decrease in the percentage of radioactivity excreted as 14-CO2 compared to a single low dose.
USEPA/Office of Pesticide Programs; Reregistration Eligibility Decision Document - 3-Iodo-2-propynyl butylcarbamate(IPBC). EPA 738-R-97-003 March 1997. Available from, as of January 31, 2005: https://www.epa.gov/pesticides/reregistration/status.htm
...IPBC undergoes reductive dehalogenation followed by dealkylation to form the URM-9 and URM-10 metabolites. In addition, de-carboxylation following reductive dehalogenation yields carbon dioxide. Various other metabolites formed from dehalogenation are glucuronidated and constitute minor metabolites of IPBC.
USEPA/Office of Pesticide Programs; Reregistration Eligibility Decision Document - 3-Iodo-2-propynyl butylcarbamate(IPBC). EPA 738-R-97-003 March 1997. Available from, as of January 31, 2005: https://www.epa.gov/pesticides/reregistration/status.htm
The carbamates are hydrolyzed enzymatically by the liver; degradation products are excreted by the kidneys and the liver. (L793)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
61
PharmaCompass offers a list of 3-Iodo-2-propynyl butylcarbamate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right 3-Iodo-2-propynyl butylcarbamate manufacturer or 3-Iodo-2-propynyl butylcarbamate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 3-Iodo-2-propynyl butylcarbamate manufacturer or 3-Iodo-2-propynyl butylcarbamate supplier.
A 3-Iodo-2-propynyl butylcarbamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3-Iodo-2-propynyl butylcarbamate, including repackagers and relabelers. The FDA regulates 3-Iodo-2-propynyl butylcarbamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3-Iodo-2-propynyl butylcarbamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 3-Iodo-2-propynyl butylcarbamate supplier is an individual or a company that provides 3-Iodo-2-propynyl butylcarbamate active pharmaceutical ingredient (API) or 3-Iodo-2-propynyl butylcarbamate finished formulations upon request. The 3-Iodo-2-propynyl butylcarbamate suppliers may include 3-Iodo-2-propynyl butylcarbamate API manufacturers, exporters, distributors and traders.
3-Iodo-2-propynyl butylcarbamate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3-Iodo-2-propynyl butylcarbamate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right 3-Iodo-2-propynyl butylcarbamate GMP manufacturer or 3-Iodo-2-propynyl butylcarbamate GMP API supplier for your needs.
A 3-Iodo-2-propynyl butylcarbamate CoA (Certificate of Analysis) is a formal document that attests to 3-Iodo-2-propynyl butylcarbamate's compliance with 3-Iodo-2-propynyl butylcarbamate specifications and serves as a tool for batch-level quality control.
3-Iodo-2-propynyl butylcarbamate CoA mostly includes findings from lab analyses of a specific batch. For each 3-Iodo-2-propynyl butylcarbamate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3-Iodo-2-propynyl butylcarbamate may be tested according to a variety of international standards, such as European Pharmacopoeia (3-Iodo-2-propynyl butylcarbamate EP), 3-Iodo-2-propynyl butylcarbamate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3-Iodo-2-propynyl butylcarbamate USP).
